Company Revenue Reports

August 8, 2022

Enovis Remains on Target for 2022 Growth Goals

Enovis Remains on Target for 2022 Growth Goals
The company's orthopedic revenue grew nearly 40% in the second quarter of 2022 on the strength of recent acquisitions like Mathys.

Funding

July 18, 2022

Graftys Closes €2 Million Investment Round

Graftys Closes €2 Million Investment Round
Funds will support commercial development and new product launches of resorbable bone cement products.

Market Reviews